A Study Of Danicopan In Participants With Geographic Atrophy Secondary To Age-Related Macular Degeneration
Jacksonville, FL
The purposes of this study are to find out whether danicopan can slow the rate of geographic atrophy (GA) disease progression and slow the loss of visual function, to see how safe danicopan is for patients with GA by monitoring for any side effects, to see how the body responds to treatment with danicopan, to measure the levels of danicopan in blood over time, to find a safe and effective dose in patients with GA and how the body deals with the study drug at different dose levels, and to see the effect of danicopan on health-related quality of ...